Please login to the form below

Not currently logged in
Email:
Password:

CEO

This page shows the latest CEO news and features for those working in and with pharma, biotech and healthcare.

Theranos and its CEO settle 'massive fraud' charges

Theranos and its CEO settle 'massive fraud' charges

Theranos and its CEO settle 'massive fraud' charges. SEC says case is a lesson in truth-telling for those seeking to disrupt an industry. ... Theranos, its CEO and former president have been charged with ‘massive fraud’in a case the US Securities and

Latest news

  • Ex-GSK CEO Witty named head of pharmacy benefit firm Optum Ex-GSK CEO Witty named head of pharmacy benefit firm Optum

    Ex-GSK CEO Witty named head of pharmacy benefit firm Optum. Current Optum CEO Larry Renfro will move to Optum Ventures as MD. ... Witty will succeed current Optum CEO Larry Renfro, who will take over leadership of the health insurer's venture capital arm

  • Teva sheds R&D chief after new CEO takes the helm Teva sheds R&D chief after new CEO takes the helm

    Teva sheds R&D chief after new CEO takes the helm. Kåre Schultz begins remoulding the Israeli pharma firm. ... Schultz has taken up the CEO position at Teva at a challenging time, with sales slumping and thousands of jobs culled as a result of pressure

  • AZ CEO says company’s renaissance is on track AZ CEO says company’s renaissance is on track

    AZ CEO says company’ s renaissance is on track. Soriot insists AZ’s strategy is working and will continue. ... Lynparza sales rose 40% to $81m in the quarter. Other pillars of the CEO’s plans for AZ delivered as hoped, with antiplatelet drug

  • Teva poaches Lundbeck's Schultz as new CEO Teva poaches Lundbeck's Schultz as new CEO

    Teva poaches Lundbeck's Schultz as new CEO. Shares in Lundbeck fall as two senior posts become vacant. ... AstraZeneca CEO Pascal Soriot and Celgene's chief operating officer Jacqualyn Fouse have both been linked with the job in the interim.

  • Vas Narasimhan takes top Novartis job on Jimenez departure Vas Narasimhan takes top Novartis job on Jimenez departure

    Vas Narasimhan takes top Novartis job on Jimenez departure. The soon-to-be CEO will take over at a time when the company has a strong pipeline. ... Swiss pharma group Novartis has said that its chief medical officer Vas Narasimhan will succeed Joe

More from news
Approximately 3 fully matching, plus 1,082 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 132 partially matching documents found.

Latest appointments

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Abeona Therapeutics names CEO. Carsten Thiel joins the biopharma from Alexion. ... Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Guido Oelkers, CEO and president of Sobi, said: “His experience from the pharmaceutical industry, numerous company integrations and the global roles he has held will be of great value for Sobi,

  • Smith & Nephew name new CEO Smith & Nephew name new CEO

    Smith &Nephew name new CEO. Namal Nawana will also become an executive director. ... Roberto Quarta, chairman of Smith &Nephew, said: “Namal has the experience as a CEO of a major listed company in the healthcare sector, and has demonstrated that he

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    evidence. Commenting on the appointment, Dorinda Hickey, CEO of Open Access Consulting, said: “We are delighted to have Jayne on board.

  • Editas Medicine names James Mullen as chairman Editas Medicine names James Mullen as chairman

    Editas Medicine names James Mullen as chairman. He has previously served as CEO of Patheon.

More from appointments
Approximately 0 fully matching, plus 644 partially matching documents found.

Latest from PMHub

  • Random42 honoured with Queen’s Award for Enterprise

    It is this success in the US that has won us The Queen’ s Award,” commented Random42 CEO and Medical Director, Ben Ramsbottom. “

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    Meet the CEO behind ReNeuron’ s cutting-edge stem cell therapies. Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’ s latest innovation in ... Image: Olav Hallebo, CEO, ReNeuron. The global stem cell market

  • Novartis CEO on patient value

    Novartis CEO on patient value. Have you been tasked with developing services that improve patient value? ... Most pharma CEOs cite the patient voice as their biggest challenge, take Joseph Jimenez’ s (CEO Novartis) recent statement in the New York

  • IBD Registry appoints first CEO

    IBD Registry appoints first CEO. The IBD Registry Board is delighted to announce the appointment of Liz Dobson as the first Chief Executive Officer of IBD Registry Ltd from 16th April ... She commented: “ I’ m delighted to be appointed as the

  • Synergy Vision appoints new Global CEO and MD following worldwide expansion

    Synergy Vision is proud to announce the appointment of Ffyona Dawber as Global CEO and Eileen Gallagher as Managing Director. ... As Global CEO, Ffyona will focus on achieving further global leverage for the company across the three offices in London,

More from PMHub
Approximately 0 fully matching, plus 185 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics